· *US stocks rose on Wednesday after the drugmaker Moderna announced that all participants in an early trial of its coronavirus vaccine candidate developed antibodies.*
· *Major indexes were also lifted by strong quarterly earnings from Goldman Sachs that handily beat analysts' profit estimates.*
· *The so-called reopening...
Dow climbs 228 points on positive vaccine data, big Goldman earnings beat
Business Insider
0 shares
1 views
You might like
Related news coverage
S&P 500 hits highest level since February as tech stocks spike
Business Insider
· *US stocks erased early losses and climbed on Monday as tech giants soared and investors cheered positive COVID-19 drug trial..
Advertisement
More coverage
Dow rallies 300 points on positive vaccine-trial data, blockbuster Goldman earnings
Business Insider
· *US stocks rose Wednesday after drugmaker Moderna announced an early coronavirus vaccine trial produced antibodies in all..
Dow climbs 230 points as investors gear up for earnings season
Business Insider
Nasdaq closes at record as traders cheer strong jobs report
Business Insider